Impax Global Equity Opportunities Fund NOK SRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 18.3 | 20.4 | -6.9 | 8.9 | 9.3 | |
+/-Cat | -5.3 | 5.8 | 11.2 | -7.1 | -2.1 | |
+/-B’mrk | - | 2.3 | 12.1 | -13.4 | -7.6 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 20/11/2024 | NOK 1.30 | |
Day Change | -0.03% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE000KIYG2F5 | |
Fund Size (Mil) 20/11/2024 | GBP 1176.35 | |
Share Class Size (Mil) 20/11/2024 | NOK 4819.53 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.49% |
Morningstar Research |
Analyst Report | 18/06/2024 Ronald van Genderen, Senior Analyst Morningstar, Inc |
Impax Global Equity Opportunities has a solid foundation in Impax's strong heritage of investing in environmental markets, extended here to sustainable investing.. It benefits from a comprehensive team that sports experience and stability. The... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 24 |
Parent | 24 |
Process | 24 |
Performance | |
Price |
Investment Objective: Impax Global Equity Opportunities Fund NOK S |
The Fund’s investment objective is to generate long term capital growth through an actively managed portfolio of equities from issuers across global equity markets. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Winborne 01/01/2018 | ||
Kirsteen Morrison 01/01/2014 | ||
Inception Date 13/12/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Not Benchmarked | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Impax Global Equity Opportunities Fund NOK S | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.20 |
Mastercard Inc Class A | Financial Services | 3.91 |
Alcon Inc | Healthcare | 3.90 |
Boston Scientific Corp | Healthcare | 3.84 |
Linde PLC | Basic Materials | 3.72 |
Increase Decrease New since last portfolio | ||
Impax Global Equity Opportunities Fund NOK S |